NSCLClung adenocarcinomaPDACCRCchronic myelomonocytic leukaemia
…dagrasib, evaluated in KRYSTAL-1, showed comparable efficacy in NSCLC (ORR ~43%, PFS 6.5 months, OS 12.6 months) and similarly receiv…
32articles mentioning diseases
96disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: PDAC ×
PDAC
This disease is selected. Its supporting articles are shown below.
Articles mentioning PDAC
32 articles · page 1 of 3PDACCA19-9BileBiomeScreen
…ng bile microbiome profiling as a promising adjunctive tool for PDAC diagnosis. Additionally, alterations in the bile microbiome wer…
CRChepatocellular carcinomagastroesophageal cancerHCCgastroesophageal carcinomacholangiocarcinomaPDAC
…allele. The top mutated genes were TP53 (71%) and APC (63%) for CRC, TP53 (76%) and CDKN2A (28%) for PDAC, GNAS (34%) and TP53 (34%…
pancreatic ductal adenocarcinomacolorectal cancerCRCPDAC
…R2 and CCR5 antagonists have demonstrated antitumor activity in pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC), respectively. This phase 1b…
PDACmetastatic pancreatic ductal adenocarcinomapancreatic ductal adenocarcinomaadvanced PDACPancreatic ductal adenocarcinoma (PDAC)
…0.01). Because CA19-9 is an established prognostic indicator in PDAC, this imbalance represents a source of residual confounding tha…
Pancreatic ductal adenocarcinoma (PDAC)PDACPACMA31
…Background Pancreatic ductal adenocarcinoma (PDAC) is characterised by a dismal prognosis and insensitivity to imm…
colorectal cancernon-small cell lung cancerpancreatic ductal adenocarcinomaPDACselective inhibitorsstandard therapies
…nocarcinoma (PDAC, 90–95%), non-small cell lung cancer (30%) or colorectal cancer (40%).1 The prognosis is particularly bad in the case of pancre…
pancreatic ductal adenocarcinomagastric and gastro-oesophageal junction cancersPDACMRTX1133CLDN18.2KPC miceO-GlcNAcylated CLDN18.2
…oesophageal junction cancers. However, its clinical efficacy in pancreatic ductal adenocarcinoma (PDAC) has been modest, suggesting the presence of regulatory m…
pancreatic cancerPDACADoBindADoBind-MMAEADoBind-DM1MC001
…otoxicity with potent immunotherapeutic properties for treating pancreatic cancer, enabling a multipronged, potentially safer treatment for a bro…
pancreatic cancerType 1 Diabetes
…sed risk of various cancers, with a particularly strong link to pancreatic cancer. 1 2 A meta-analysis found that individuals with type 1 diabete…
pancreatic ductal adenocarcinomaPNET/Cpancreatic neuroendocrine tumor/carcinomabenign lesionsPDACRuijin HospitalROSE
…r cytologic classification of SPLs). The target categories were pancreatic ductal adenocarcinoma (PDAC), pancreatic neuroendocrine tumor/carcinoma (PNET/C), and…
Type 2 Diabetes mellitus-relatedPancreatic adenocarcinomaType 2 Diabetes mellitusPancreatic ductal adenocarcinomaT2DMPDACPDAC-T2DM-related
…igure 1Overall and sex-stratified Pancreatic adenocarcinoma and Type 2 Diabetes mellitus-related age-adjusted mortality rates per 1,000,000 in the United States…